Spotlight on Genomics
Lukas Wartman, MD, conducts research in 2011 prior to his second leukemia relapse.
Siteman Cancer Center physician Lukas Wartman, MD, has been battling leukemia for a decade. He has been researching methods to treat the disease for nearly as long.
The cutting-edge genetic research at Siteman and Washington University that saved his life was recently featured in The New York Times and on CBS This Morning and Charlie Rose.
Wartman's extradorinary case has been watched closely, as it gives a true glimpse into personalized cancer treatment.
More stories of genomic innovation
The young doctor was first diagnosed with adult acute lymphoblastic leukemia in 2003 and has since survived two relapses of the disease. Surviving a second relapse of leukemia is almost unheard of. But after sequencing his normal cells, cancer cells and RNA, his treatment team was able to put his leukemia back into remission with a drug used in the treatment of kidney cancer.
And while Wartman continues to battle graft-versus-host disease after receiving a second bone marrow transplant, he has been able to continue his research in Timothy Ley, MD's, lab.